Limited T cell response to SARS-CoV-2 mRNA vaccine among patients with cancer receiving different cancer treatments.

INTRODUCTION: Patients with cancer (PC) are at high risk of acquiring COVID-19 and can develop more serious complications. Deeper understanding of vaccines immunogenicity in this population is crucial for adequately planning vaccines programs. The ONCOVac study aimed to comprehensively assess the immunogenicity of mRNA-1273 vaccine in terms of humoral and cellular response. METHODS: We conducted a prospective, single-center study including patients with solid tumours treated with cyclin-dependent kinases 4 and 6 inhibitors (CDK4/6i), immunotherapy (IT) or chemotherapy (CT). Patients were enrolled previously to vaccination with mRNA-1273. We also involved health care workers (HCW) to serve as a control group. We took blood samples before first dose administration (BL), after first dose (1D), and after second dose (2D). The primary objective was to compare the rate and magnitude of T cell response after second dose whereas safety and humoral response were defined as secondary objectives. We also collected patient reported outcomes after both the first and second vaccine dose and a six-month follow-up period to diagnose incident COVID-19 cases was planned. RESULTS: The rate of specific anti-S serologic positivity (anti-S IgG cut-off point at 7,14 BAU/mL) was significantly higher in HCW compared to PC after 1D (100% versus 83.8%; p = 0.04), but similar after 2D (100% versus 95.8%; p = 0.5). This difference after 1D was driven by PC treated with CT (100% versus 64.5%; p = 0.001). Cellular response after 2D was significantly lower in PC than in HCW for both CD4+ (91.7% versus 59.7%; p = 0.001) and CD8+ (94.4% versus 55.6%; p < 0.001) T cells. We found a difference on pre-existing CD4+ T cell response in HCW comparing to PC (36% and 17%, p = 0.03); without difference in pre-existing CD8+ T cell response (31% and 23%, p = 0.5). After excluding patients with pre-existing T cell response, PC achieved even lower CD4+ (50.9% versus 95.5%, p < 0.001) and CD8+ (45.5% versus 95.5%, p < 0.001) T cell response compared with HCW. Regarding safety, PC reported notably more adverse events than HCW (96.6% versus 69.2%, p < 0.001). CONCLUSION: We demonstrated that PC showed a similar humoral response but a lower T cell response following two doses of mRNA-1273 vaccination. Further studies are needed to complement our results and determine the implication of low T cell response on clinical protection of PC against COVID-19.

Prevalencia de infección por Demodex folliculorum en pacientes que acuden a consulta general de oftalmología / The prevalence of Demodex folliculorum infection in patients attending a general ophthalmological consultation

Objetivos Determinar la prevalencia de infección por Demodex folliculorum en pacientes que asisten a consulta general de oftalmología, y su asociación con blefaritis. Métodos Estudio descriptivo de prevalencia. En forma aleatoria se seleccionaron 128 sujetos que asistieron al Centro Oftalmológico Virgilio Galvis y se determinó la presencia de Demodex folliculorum en 4 pestañas de cada uno. Resultados La prevalencia de infección por Demodex folliculorum fue 42,1 % (n= 54). Se diagnosticó blefaritis en el 38,3 % de los pacientes (n=49) y el 63,2 % de ellos (n=31) fueron positivos para D. folliculorum. En el grupo sin blefaritis (n=79) solo el 29,2 % de los individuos tenían el ácaro (n=23) (p=0.0003). Además se encontró una mayor cantidad de parásitos en los pacientes con blefaritis (índice de carga parasitaria 12,7 vs 5,1 (p=0.0001). El 25 % (n=32) de los participantes presentaban descamación en forma de cilindros y en estos el 96,9 % tenían el ácaro (n= 31), mientras que en los sujetos que no tenían cilindros (n=96) el ácaro estuvo presente solo en el 24 % (n=23). Conclusiones El Demodex folliculorum es un parásito que se encuentra en personas sin lesiones oculares, pero que es más frecuente y presenta una mayor carga parasitaria en pacientes con blefaritis. Nuestros resultados sugieren la necesidad de investigar la presencia de Demodex folliculorum en todo paciente con blefaritis y especialmente en los casos en que se observe presencia de descamación en forma de cilindros en las pestañas.

Objectives Determining Demodex folliculorum infection prevalence in patients attending general ophthalmological consultation and such infection's association with blepharitis. Methods This was a descriptive study of such prevalence. 128 subjects who attended the Virgilio Galvis Eye Centre were randomly selected and the presence of D. folliculorum was determined in 4 eyelashes taken from each of them. Results D. folliculorum infection prevalence was 42.1 % (n=54); blepharitis was diagnosed in 38.3 % of the patients (n=49) and 63.2 % of them (n=31) were positive for D. folliculorum. Only 29.2 % of the individuals in the group without blepharitis (n=79) had mites (n=23) (p=0.0003). A higher number of parasites was found in patients with blepharitis (12.7 parasitic load index cf 5.1; p=0.0001); 25 % (n=32) of the participants had scaling in the form of cylinders and 96.9 % of these had the mites (n=31), whereas the mite was only present in 24 % (n=23) of subjects who had no cylinder-type scaling (n=96). Conclusions Demodex folliculorum is a parasite found in people without ocular lesions; however, it is more frequent and has a higher parasite burden in patients with blepharitis. Our results suggested the need for investigating the presence of D. folliculorum in all patients suffering from blepharitis, especially in cases where cylinder-type scaling has been observed in their eyelashes.

[The prevalence of Demodex folliculorum infection in patients attending a general ophthalmological consultation]. / Prevalencia de infección por Demodex folliculorum en pacientes que acuden a consulta general de oftalmología.

OBJECTIVES: Determining Demodex folliculorum infection prevalence in patients attending general ophthalmological consultation and such infection's association with blepharitis. METHODS: This was a descriptive study of such prevalence. 128 subjects who attended the Virgilio Galvis Eye Centre were randomly selected and the presence of D. folliculorum was determined in 4 eyelashes taken from each of them. RESULTS: D. folliculorum infection prevalence was 42.1% (n=54); blepharitis was diagnosed in 38.3% of the patients (n=49) and 63.2% of them (n=31) were positive for D. folliculorum. Only 29.2% of the individuals in the group without blepharitis (n=79) had mites (n=23) (p=0.0003). A higher number of parasites was found in patients with blepharitis (12.7 parasitic load index cf 5.1; p=0.0001); 25% (n=32) of the participants had scaling in the form of cylinders and 96.9% of these had the mites (n=31), whereas the mite was only present in 24% (n=23) of subjects who had no cylinder-type scaling (n=96). CONCLUSIONS: Demodex folliculorum is a parasite found in people without ocular lesions; however, it is more frequent and has a higher parasite burden in patients with blepharitis. Our results suggested the need for investigating the presence of D. folliculorum in all patients suffering from blepharitis, especially in cases where cylinder-type scaling has been observed in their eyelashes.